Advent Acquires Majority Stake in New Zealand Clinical Research Group
US-based Advent, a leading global private equity investor, has signed a definitive agreement to acquire a majority shareholding in New Zealand Clinical Research Group (NZCR Group), a leading clinical trials and medical research organisation in New Zealand and Australia. NZCR Group’s clinician shareholders and management, along with local private equity investor Waterman Capital, are retaining
Advent Acquires Majority Stake in New Zealand Clinical Research Group Read More »
